World Of Taxonomy
50242-061Level 3

Avastin (bevacizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** BEVACIZUMAB

**Strength:** 400 mg/16mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA125085)

**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

GET/api/v1/systems/ndc_fda/nodes/50242-061
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.